An official website of the United States government
Telemedicine Use Among Adults With and Without Diagnosed Prediabetes or Diabetes, National Health Interview Survey, United States, 2021 and 2022
RESEARCH BRIEF — Volume 21 — November 14, 2024
Updated November 14, 2024
PEER REVIEWED
Figure.
Unadjusted prevalence of telemedicine use in the past 12 months among adults with and without diagnosed prediabetes or diabetes. Prevalence (%) and associated 95% CIs are weighted; error bars indicate 95% CIs. For each population, differences between 2021 and 2022 were significant (all P< .05). Source: National Health Interview Survey, 2021 and 2022.
| Diagnosis | 2021 | 2022 |
|---|---|---|
| % (95% CI) | ||
| No diagnosed prediabetes or diabetes | 34.1 (33.3–35.0) | 28.2 (27.4–29.1) |
| Diagnosed prediabetes | 47.6 (45.4–49.8) | 37.6 (35.3–40.0) |
| Diagnosed diabetes | 52.8 (50.6–54.9) | 39.4 (37.2–41.6) |
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.